Medical technology company developing sacral neuromodulation therapies for the treatment of urinary and bowel dysfunction.
Axonics, Inc., a pioneering medical technology firm, specializes in the advancement and commercialization of sacral neuromodulation (SNM) systems. These innovative systems are designed to effectively manage a range of conditions such as overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Central to Axonics' offerings is their rechargeable SNM System (r-SNM), which administers gentle electrical impulses to the sacral nerve, facilitating normalized communication between the brain and the bladder or bowel, thereby alleviating symptoms of dysfunction.
In addition to its flagship SNM systems, Axonics, Inc. markets Bulkamid, a specialized urethral bulking agent developed primarily for the treatment of female stress urinary incontinence. This diversified product portfolio underscores Axonics' commitment to addressing various facets of urological health through cutting-edge technology and therapeutic solutions. The company operates through a multifaceted distribution strategy, leveraging both direct sales teams and partnerships with distributors across key markets including the United States, the United Kingdom, Germany, the Netherlands, the Nordic countries, and beyond.
Originally established as Axonics Modulation Technologies, Inc., the company rebranded to Axonics, Inc. in March 2021. Since its inception in 2012, Axonics has been headquartered in Irvine, California, strategically positioning itself within a hub of medical and technological innovation. Guided by a commitment to enhancing patient outcomes and quality of life, Axonics continues to drive advancements in neuromodulation therapies, making significant strides in the field of urology and beyond.
Axonics, Inc. remains dedicated to expanding its global footprint while maintaining a steadfast focus on innovation and clinical excellence. Through ongoing research and development efforts, Axonics endeavors to redefine standards of care in urological health, offering hope and improved quality of life for patients worldwide.